[PHARMA] YoY TTM Result on 31-Mar-2008 [#1]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
28-May-2008
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2008
Quarter
31-Mar-2008 [#1]
Profit Trend
QoQ- 24.91%
YoY- 377.86%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
TTM Result
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
Revenue 1,446,116 1,304,640 1,309,712 1,237,398 1,063,349 959,313 836,558 9.54%
PBT 54,823 73,685 83,409 95,042 28,514 32,734 79,358 -5.97%
Tax -18,223 -17,340 -26,289 -30,835 -13,853 -9,671 -30,208 -8.07%
NP 36,600 56,345 57,120 64,207 14,661 23,063 49,150 -4.79%
-
NP to SH 36,561 54,977 56,008 62,556 13,091 21,662 49,150 -4.80%
-
Tax Rate 33.24% 23.53% 31.52% 32.44% 48.58% 29.54% 38.07% -
Total Cost 1,409,516 1,248,295 1,252,592 1,173,191 1,048,688 936,250 787,408 10.18%
-
Net Worth 437,661 439,675 402,378 367,905 321,111 335,032 257,266 9.25%
Dividend
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
Div 50,261 97,382 48,140 35,295 12,310 14,388 15,245 21.98%
Div Payout % 137.47% 177.13% 85.95% 56.42% 94.04% 66.42% 31.02% -
Equity
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
Net Worth 437,661 439,675 402,378 367,905 321,111 335,032 257,266 9.25%
NOSH 107,007 106,977 107,015 106,949 107,037 107,039 102,089 0.78%
Ratio Analysis
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
NP Margin 2.53% 4.32% 4.36% 5.19% 1.38% 2.40% 5.88% -
ROE 8.35% 12.50% 13.92% 17.00% 4.08% 6.47% 19.10% -
Per Share
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
RPS 1,351.41 1,219.55 1,223.85 1,157.00 993.44 896.23 819.43 8.69%
EPS 34.17 51.39 52.34 58.49 12.23 20.24 48.14 -5.55%
DPS 47.00 91.00 45.00 33.00 11.50 13.44 15.00 20.95%
NAPS 4.09 4.11 3.76 3.44 3.00 3.13 2.52 8.40%
Adjusted Per Share Value based on latest NOSH - 106,949
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
RPS 100.34 90.52 90.87 85.86 73.78 66.56 58.04 9.54%
EPS 2.54 3.81 3.89 4.34 0.91 1.50 3.41 -4.78%
DPS 3.49 6.76 3.34 2.45 0.85 1.00 1.06 21.95%
NAPS 0.3037 0.3051 0.2792 0.2553 0.2228 0.2325 0.1785 9.25%
Price Multiplier on Financial Quarter End Date
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
Date 31/03/11 31/03/10 31/03/09 31/03/08 30/03/07 31/03/06 31/03/05 -
Price 5.73 4.27 3.45 2.95 3.55 4.73 4.82 -
P/RPS 0.42 0.35 0.28 0.25 0.36 0.53 0.59 -5.50%
P/EPS 16.77 8.31 6.59 5.04 29.03 23.37 10.01 8.97%
EY 5.96 12.04 15.17 19.83 3.45 4.28 9.99 -8.24%
DY 8.20 21.31 13.04 11.19 3.24 2.84 3.11 17.52%
P/NAPS 1.40 1.04 0.92 0.86 1.18 1.51 1.91 -5.04%
Price Multiplier on Announcement Date
31/03/11 31/03/10 31/03/09 31/03/08 31/03/07 31/03/06 31/03/05 CAGR
Date 13/05/11 26/05/10 08/05/09 28/05/08 25/05/07 25/05/06 18/05/05 -
Price 5.05 4.71 3.82 3.45 3.45 4.53 4.86 -
P/RPS 0.37 0.39 0.31 0.30 0.35 0.51 0.59 -7.47%
P/EPS 14.78 9.16 7.30 5.90 28.21 22.38 10.09 6.56%
EY 6.77 10.91 13.70 16.95 3.55 4.47 9.91 -6.15%
DY 9.31 19.32 11.78 9.57 3.33 2.97 3.09 20.16%
P/NAPS 1.23 1.15 1.02 1.00 1.15 1.45 1.93 -7.23%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment